DIPHENHYDRAMINE HYDROCHLORIDE CAPSULES

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the supply of 10,000 bottles of DIPHENHYDRAMINE HYDROCHLORIDE CAPSULES, identified by NSN 6505011533272, at a total contract value of $31.90. The award, issued on July 21, 2026, was made under NAICS code 424210 for pharmaceutical merchant wholesalers, with delivery mandated to be completed by August 5, 2026, at Fort Bliss, Texas, under FOB destination terms where the contractor bears full responsibility for transportation and associated costs. The quantity variance is strictly zero percent, requiring exact delivery without tolerance for over or under shipment, and parcel post is explicitly prohibited, with traceable shipping methods required and a specific Transportation Control Number W8001Z62010183 mandated for shipment tracking. While no formal contract clauses, special requirements, or evaluation factors were detailed in the provided documentation, the transaction strongly suggests a Lowest Price Technically Acceptable award process typical of DLA’s low-value pharmaceutical procurements. The contract lacks explicit references to FDA, USP, or MIL-STD standards for quality or packaging, and no representations regarding small business status, socioeconomic certifications, or subcontracting plans were disclosed. The remittance and payment office details are omitted, and the invoicing method is unspecified, though the delivery address and funding identifiers such as DIC A0A, FC Z9, and SUPP ADD W9046W are provided. No attachments, compliance certifications, or contracting officer contact details are listed, and while the award notice references an underlying solicitation, no amendment numbers, proposal submission guidelines, or electronic platform instructions are included, indicating a highly streamlined administrative process focused solely on fulfillment of a single-line-item, fixed-price pharmaceutical delivery.